Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
Introduction: Antimicrobial treatments for carbapenem-resistant Enterobacteriaceae (CRE) bacteremia are limited, with colistin-based regimens being a primary therapy. Ceftazidime–avibactam is an emerging treatment for various CRE infections. Our study aimed to assess ceftazidime–avibactam effectiven...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2021-08-01
|
| סדרה: | International Journal of Infectious Diseases |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1201971221004835 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|